M&A Ahead: Ten Potential Medtech Takeover Targets
This article was originally published in The Gray Sheet
Executive Summary
Device firms have already been active with M&A deals in 2014. Here are 10 companies to look for as potential acquisition targets going forward.
You may also be interested in...
Editors' Picks: Six Themes From 2014
Industry closely scrutinized FDA's premarket review performance as the agency took steps to streamline reviews and remake the U.S. postmarket surveillance system. Meanwhile: device mega-mergers accelerated; one of the most hotly anticipated medtech innovations faltered; and national elections swept in Republican control of Congress. Here is a look back at coverage and analysis from "The Gray Sheet" on six key themes for the medical device and diagnostics industry in 2014.
Philips Increases Bet On Imaged-Guided Therapy With Volcano Buy
The imaging giant's $1.2 billion acquisition of intravascular assessment specialist Volcano deepens Philips' play in hospital cath labs and, Philips' CEO says in an interview, provides a combination of technology and know-how to create new catheter-based therapies for high-growth disease markets.
Wright Moves More To Extremes With Tornier Purchase Agreement
The all-stock transaction valued at around $3.3 billion will create a device and biologics company with a comprehensive focus on orthopedic extremities surgery. The firms expect cost synergies of $40 to $45 million.